Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non–Small-Cell Lung Cancer after Neoadjuvant Chemotherapy

医学 实体瘤疗效评价标准 化疗 比例危险模型 肺癌 新辅助治疗 阶段(地层学) 临床终点 癌症 放射科 肿瘤科 内科学 进行性疾病 临床试验 乳腺癌 古生物学 生物
作者
William N. William,Apar Pataer,Neda Kalhor,Arlene M. Correa,David C. Rice,Ignacio Ivan Wistuba,John Victor Heymach,J. Jack Lee,Edward S. Kim,Reginald F. Munden,Kathryn Ann Gold,Vassiliki A. Papadimitrakopoulou,Stephen G. Swisher,Jeremy J. Erasmus
出处
期刊:Journal of Thoracic Oncology [Elsevier BV]
卷期号:8 (2): 222-228 被引量:138
标识
DOI:10.1097/jto.0b013e3182774108
摘要

This study's objectives were to determine whether tumor response measured by computed tomography (CT) and evaluated using Response Evaluation Criteria in Solid Tumors (RECIST) correlated with overall survival (OS) in patients with non-small-cell lung cancer (NSCLC) after neoadjuvant chemotherapy and surgical resection.We measured primary tumor size on CT before and after neoadjuvant chemotherapy in 160 NSCLC patients who underwent surgical resection. The relationship between CT-measured response (RECIST) and histopathologic response (≤ 10% viable tumor) and OS were assessed by Kaplan-Meier survival, univariable, and multivariable Cox proportional hazards regression.There was a statistically significant association between CT-measured response (RECIST) and OS (p = 0.03). However, histopathologic response was a stronger predictor of OS (p = 0.002), with a more pronounced separation of the survival curves when compared with CT-measured response. In multivariable Cox regression analysis, only pathologic stage and histopathologic response were significant predictors of OS. A 41% overall discordance rate was noted between CT RECIST response and histopathologic response. CT RECIST classified as nonresponders a subset of patients with histopathologic response (8 out of 30 points, 27%) who demonstrated prolonged survival after neoadjuvant chemotherapy.We were unable to show that CT RECIST is a reliable predictor of OS in patients with NSCLC undergoing surgical resection after neoadjuvant chemotherapy. The failure of CT RECIST to predict long-term outcome may be because of the inability of CT imaging to consistently identify patients with histopathologic response. CT RECIST may have only a limited role as an efficacy endpoint after neoadjuvant chemotherapy in patients with resectable NSCLC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刘承昭发布了新的文献求助10
刚刚
刚刚
Alioth发布了新的文献求助10
刚刚
刚刚
蒸汽秋葵的应助被无限凛采纳,获得10
刚刚
刚刚
刚刚
1秒前
cy完成签到,获得积分10
2秒前
酱酱完成签到 ,获得积分10
2秒前
kqb关注了科研通微信公众号
2秒前
LAN完成签到,获得积分10
2秒前
JJ完成签到,获得积分10
2秒前
liannan完成签到,获得积分10
2秒前
lixiang发布了新的文献求助10
3秒前
刘荣鑫完成签到 ,获得积分10
3秒前
Akim的应助被刘承昭采纳,获得10
3秒前
3秒前
4秒前
4秒前
innyjiang发布了新的文献求助10
5秒前
Bright完成签到 ,获得积分10
5秒前
liannan发布了新的文献求助10
5秒前
一颗苹果完成签到 ,获得积分10
5秒前
5秒前
ShangQ完成签到,获得积分10
5秒前
zhang的应助被Davidfly20采纳,获得200
5秒前
04d的应助被windcreator采纳,获得10
5秒前
Takahara2000发布了新的文献求助10
5秒前
极品小亮完成签到,获得积分10
5秒前
6秒前
脑洞疼的应助被仁爱的沁采纳,获得10
6秒前
Ken完成签到,获得积分10
6秒前
wmwing发布了新的文献求助10
6秒前
6秒前
顺利人杰完成签到 ,获得积分10
6秒前
6秒前
YukiXu完成签到,获得积分10
7秒前
马宇驰发布了新的文献求助10
8秒前
可爱的函函的应助被shen采纳,获得30
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160467
求助须知:如何正确求助?哪些是违规求助? 9555463
关于积分的说明 21728123
捐赠科研通 7750270
什么是DOI,文献DOI怎么找? 3427393
关于科研通互助平台的介绍 2552425
邀请新用户注册赠送积分活动 2471741